These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6507 related articles for article (PubMed ID: 3516075)

  • 1. [Distribution of BCG antigens in mouse-tumor cells].
    Sasaki J; Sawamura D; Kamiya S; Yamatani S; Satoh K; Fukushi K
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1074-6. PubMed ID: 3516075
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects on tumor growth in vivo by manipulation of the tumor immune response.
    Sjögren HO
    Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells.
    Bucana C; Hanna MG
    J Natl Cancer Inst; 1974 Nov; 53(5):1313-23. PubMed ID: 4139279
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression of murine tumor growth by immune reaction to the Bacillus Calmette-Guérin strain of Mycobacterium bovis.
    Bartlett GL; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1972 Jan; 48(1):245-57. PubMed ID: 4568964
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancing effect of coenzyme, Q10 on immunorestoration with Mycobacterium bovis BCG in tumor-bearing mice.
    Kawase I; Niitani H; Saijo N; Sasaki H; Morita T
    Gan; 1978 Aug; 69(4):493-7. PubMed ID: 101414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.
    Yron I; Weiss DW; Robinson E; Cohen D; Adelberg MG; Mekori T; Haber M
    Natl Cancer Inst Monogr; 1973 Dec; 39():33-55. PubMed ID: 4362523
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytotoxicity in vitro by products of specifically stimulated spleen cells: susceptibility of tumor cells and normal cells.
    Meltzer MS; Bartlett GL
    J Natl Cancer Inst; 1972 Nov; 49(5):1439-43. PubMed ID: 4568090
    [No Abstract]   [Full Text] [Related]  

  • 9. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
    [No Abstract]   [Full Text] [Related]  

  • 10. Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.
    Minden P; McClatchy JK; Wainberg M; Weiss DW
    J Natl Cancer Inst; 1974 Nov; 53(5):1325-31. PubMed ID: 4139280
    [No Abstract]   [Full Text] [Related]  

  • 11. [Shared antigens between BCG and tumor cells--immunotherapy with BCG for mouse tumor].
    Sasaki J; Kanda S; Sawamura D; Kamiya S; Inaba Y; Kawashima M
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1432-9. PubMed ID: 4015119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Distribution of human alpha-fetoprotein in animal tumor cells].
    Sasaki J; Rafigul AC; Lü CL; Tamagake T
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3305-8. PubMed ID: 2461682
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced tumorigenicity of B16-F10 mouse melanoma cells transfected with mycobacterial antigen 85A.
    Tarrant JP; Walsh MJ; Blanchard MC; Lee TD; Hoskin DW; Giacomantonio CA
    Int J Oncol; 2004 Dec; 25(6):1693-9. PubMed ID: 15547707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of common sarcoma-associated antigen(s) in an established human neurogenic sarcoma cell line.
    Drewinko B; Montgomery CT; Trujillo JM
    Cancer Res; 1973 Mar; 33(3):601-5. PubMed ID: 4347719
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
    Rios A; Simmons RL
    Cancer Res; 1972 Jan; 32(1):16-21. PubMed ID: 4550256
    [No Abstract]   [Full Text] [Related]  

  • 16. Some aspects of the cellular and humoral immune response to tumour antigens.
    Hellström KE; Hellström I
    Triangle; 1972; 11(1):23-8. PubMed ID: 4624858
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro].
    Reisser D; Jeannin JF; Martin F
    C R Seances Acad Sci III; 1982 Nov; 295(8):485-8. PubMed ID: 6819063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antigens common to Mycobacterium bovis (BTsZh) and several malignant and normal tissues of laboratory animals].
    Lomakin MS; Maĭskiĭ IN; Mamaeva TN; Larin AS; Levitina VL
    Biull Eksp Biol Med; 1977 Jan; 83(1):65-8. PubMed ID: 403974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Definition of tumor-necrosis factor and its production mechanism].
    Urushizaki I; Niitsu Y; Watanabe N
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1356-68. PubMed ID: 6378100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic analysis between BCG and tumor cells by BCG-monoclonal antibodies.
    Sasaki J; Kitagawa M; Tamagake T; Narita S; Ahsan CR; Lu CL
    Microbiol Immunol; 1989; 33(11):951-5. PubMed ID: 2687649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 326.